NEW YORK (GenomeWeb News) — The National Institutes of Health has awarded a Small Business Innovation Research grant to DNAStar to fund the development of software for engineering antibodies.
DNAStar said this week that the tool that it will develop using the funds from the NIH is "a key step" in its ongoing efforts to build a comprehensive desktop proteomics software suite.
In a statement, DNAStar VP and GM Tom Schwei said that the company has for several years been building "a foundation for our emerging proteomics platform in Protean 3D within our Lasergene software suite."
He said that the NIH grant "will help us move quickly to develop a key component of our vision for our proteomics suite — creating a tool to produce superior epitope prediction and antibody engineering results compared to today's available methods and tools."
The company also plans to include tools for protein structure prediction, protein motion, and molecular interactions in its proteomics suite, Schwei said.